ARTICLE | Clinical News
Remimazolam: Phase III started
April 13, 2015 7:00 AM UTC
Paion began a double-blind, placebo-controlled, U.S. Phase III trial to compare IV remimazolam vs. midazolam in about 460 patients undergoing colonoscopy. Patients will receive 5 mg remimazolam for in...